What is calciphylaxis with underlying steal syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calciphylaxis with Underlying Steal Syndrome: Understanding the Connection

Calciphylaxis with underlying steal syndrome is a complex condition where vascular calcification leads to ischemic skin ulceration, exacerbated by blood flow diversion from peripheral tissues due to arteriovenous access, resulting in severe tissue ischemia, painful non-healing wounds, and high mortality risk. 1, 2

Pathophysiology and Clinical Presentation

  • Calciphylaxis is characterized by vascular calcification leading to ischemic skin ulceration, primarily affecting patients with chronic kidney disease, especially those on dialysis 1, 3
  • When calciphylaxis occurs with steal syndrome, there is a compounding effect where:
    • Arterial blood flow is shunted through the arteriovenous (AV) access and away from peripheral tissues 2
    • This diversion of blood exacerbates the already compromised circulation from vascular calcification 3, 4
  • The prevalence of steal syndrome ranges from 1% to 20% in dialysis patients with AV access, while calciphylaxis is relatively rare with high mortality 2, 5

Clinical Manifestations

  • Initial presentation includes painful, violaceous, mottled lesions that progress to skin and subcutaneous tissue necrosis 6
  • When combined with steal syndrome, symptoms may include:
    • Progressive digital ischemia ranging from mild numbness to severe motor impairment 2
    • Pain during and between dialysis sessions 2
    • Skin ulceration or gangrene that may necessitate digit or limb amputation 2
  • The condition can be staged according to severity 2:
    • Stage I: pale/blue and/or cold hand without pain
    • Stage II: pain during exercise and/or hemodialysis
    • Stage III: pain at rest
    • Stage IV: ulcers/necrosis/gangrene

Diagnostic Approach

  • Laboratory testing has limitations in diagnosing calciphylaxis 1:
    • C-reactive protein is the most helpful laboratory test, reflecting the inflammatory component
    • Serum calcium and phosphate levels are not reliably predictive
  • For steal syndrome, diagnostic approaches include 7:
    • Blood pressure measurement in both arms to identify asymmetry
    • Duplex ultrasonography to identify reversal of flow in the vertebral artery
    • CTA or MRA to identify arterial stenosis
  • Skin biopsy for calciphylaxis has significant limitations with variable sensitivity (20-80%) 1

Risk Factors

  • Common risk factors for calciphylaxis include 1, 4:
    • Chronic kidney disease, especially end-stage renal disease
    • High doses of active vitamin D derivatives
    • Vitamin K antagonism or deficiency (increases risk up to 11-fold)
    • Inflammation (detected by elevated C-reactive protein)
  • Steal syndrome is more common in 2:
    • Elderly and hypertensive patients
    • Patients with diabetes
    • Those with peripheral arterial occlusive disease
    • Patients with proximal accesses supported by brachial artery inflow

Management Approach

For Calciphylaxis Component:

  • Early recognition and multimodal treatment are essential to improve survival 6, 8
  • Multidisciplinary collaboration including nephrology, dermatology, and wound care specialists 8
  • Sodium thiosulfate has shown promise in treatment, though large clinical trials are needed 5

For Steal Syndrome Component:

  • Surgical options include 2:
    • DRIL (Distal Revascularization and Interval Ligation) - preferred surgical management with higher fistula preservation rates
    • Revision using distal inflow
    • Distal radial artery ligation
    • Proximalization of arterial inflow
    • Banding (though this has higher failure rates)
  • Endovascular approaches may be more suitable for forearm fistulae due to vessel size and calcification 2

Potential Complications and Pitfalls

  • Without prompt intervention, calciphylaxis with steal syndrome can lead to 2, 6:
    • Severe tissue necrosis
    • Wound-related sepsis
    • Limb loss
    • Death (mortality rates are high even with intervention)
  • Delayed recognition significantly worsens prognosis 6
  • Banding procedures alone have historically shown poor success rates 2

Monitoring and Follow-up

  • Regular monitoring of dialysis access for signs of steal syndrome should be conducted in all dialysis facilities 2
  • C-reactive protein levels can help monitor inflammatory response to treatment 1
  • Patients require close follow-up for wound healing and potential recurrence 8

References

Guideline

Laboratory Testing for Diagnosing Calciphylaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An Update on Calciphylaxis.

American journal of clinical dermatology, 2018

Research

Review: update on the management of calciphylaxis.

QJM : monthly journal of the Association of Physicians, 2019

Research

Calciphylaxis: diagnosis and clinical features.

Clinical and experimental nephrology, 2013

Research

Calciphylaxis: early recognition and management.

The American surgeon, 1994

Guideline

Management of Subclavian Steal Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Calciphylaxis and Kidney Disease: A Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.